Banque Cantonale Vaudoise’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
18,816
+4,241
| +29% | +$293K | 0.05% | 314 |
|
|
2025
Q1 | $1.01M | Buy |
+14,575
| New | +$1.01M | 0.04% | 352 |
|
|
2024
Q3 | $1.15M | Sell |
9,650
-173
| -2% | -$20.6K | 0.05% | 297 |
|
|
2024
Q2 | $1.4M | Sell |
9,823
-444
| -4% | -$63.4K | 0.06% | 288 |
|
|
2024
Q1 | $1.32M | Buy |
10,267
+9,603
| +1,446% | +$1.23M | 0.05% | 317 |
|
|
2023
Q4 | $69K | Hold |
664
| – | – | ﹤0.01% | 746 |
|
|
2023
Q3 | $60K | Sell |
664
-726
| -52% | -$65.6K | ﹤0.01% | 939 |
|
|
2023
Q2 | $113K | Sell |
1,390
-926
| -40% | -$75.3K | 0.01% | 837 |
|
|
2023
Q1 | $184K | Sell |
2,316
-1,284
| -36% | -$102K | 0.01% | 717 |
|
|
2022
Q4 | $243K | Sell |
3,600
-336
| -9% | -$22.7K | 0.01% | 659 |
|
|
2022
Q3 | $197K | Buy |
3,936
+412
| +12% | +$20.6K | 0.01% | 722 |
|
|
2022
Q2 | $197K | Buy |
3,524
+106
| +3% | +$5.93K | 0.01% | 739 |
|
|
2022
Q1 | $189K | Sell |
3,418
-1,352
| -28% | -$74.8K | 0.01% | 797 |
|
|
2021
Q4 | $267K | Sell |
4,770
-276
| -5% | -$15.4K | 0.01% | 756 |
|
|
2021
Q3 | $242K | Sell |
5,046
-264
| -5% | -$12.7K | 0.01% | 747 |
|
|
2021
Q2 | $222K | Buy |
+5,310
| New | +$222K | 0.01% | 815 |
|